SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (4699)7/2/1998 12:32:00 PM
From: Steve Fancy  Read Replies (2) of 6136
 
Well, I'm the fool, this Remune data was released yesterday...apparently nothing today, and an oral presentation in a late-breaker session is scheduled for tomorrow.

Mrs Wong reiterates again her 12 month price target of $65-$70. If she would wake up, smell the coffee, and offer a reasonable 12-month price target, someone might listen. She obviously has no impact any longer...if she ever did. I have to laugh when I read her reports, as I wonder if her price target is as of this report, the last report, any report from last year, or reports from '96. Guess we need to wait for Doug Lind...or worse Crossen.

If this d**n stock breaks 28, watch for a new 52-week low around 25-26. Maybe earnings anticipation will help put things in check, but estimated dates have them reporting the end of July, so it may be on its own for a couple weeks yet.

I'll post the short document I have from Paine Webber in a while.

sf
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext